Alexander Levitzki
42Patents
12h-index
48Co-inventors
81Inventor score
Filing activity: Apr 16, 1991 → Sep 27, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5217999A | Styryl compounds which inhibit EGF receptor protein tyrosine kinase | Chemistry; Metallurgy | 183 | Expired |
| US5302606A | Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase | Chemistry; Metallurgy | 176 | Expired |
| US5773476A | Methods and compositions for inhibiting cell proliferative disorders | Chemistry; Metallurgy | 85 | Expired |
| US5792771A | Quinazoline compounds and compositions thereof for the treatment of disease | Physics | 82 | Expired |
| US5712395A | Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis | Physics | 64 | Expired |
| US5763441A | Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis | Physics | 53 | Expired |
| US5932580A | PDGF receptor kinase inhibitory compounds their preparation and compositions | Chemistry; Metallurgy | 51 | Expired |
| US5196446A | Certain indole compounds which inhibit EGF receptor tyrosine kinase | Chemistry; Metallurgy | 48 | Expired |
| US6562319B2 | Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy | Human Necessities | 38 | Expired |
| US6126917A | Epidermal growth factor receptor binding compounds for positron emission tomography | Human Necessities | 36 | Expired |
| US5981569A | Substituted phenylacrylonitrile compounds and compositions thereof for the treatment of disease | Physics | 36 | Expired |
| US6596878B2 | Methods and compositions for inhibiting cell proliferative disorders | Chemistry; Metallurgy | 15 | Expired |
| US5849742A | Compounds for the treament of disorders related to vasculogenesis and/or angiogenesis | Physics | 12 | Expired |
| US5656655A | Styryl-substituted heteroaryl compounds which inhibit EGF receptor tyrosine kinase | Chemistry; Metallurgy | 12 | Expired |
| US6426366B1 | Pharmaceutical compositions comprising tyrphostins | Human Necessities | 10 | Expired |
| USRE38761E1 | Styryl compounds which inhibit EGF receptor protein tyrosine kinase | General | 9 | Expired |
| US8058309B2 | Protein kinase modulators and therapeutic uses thereof | Human Necessities | 6 | Active |
| US7745468B2 | Compounds for treatment of cell proliferative diseases | Chemistry; Metallurgy | 6 | Active |
| US9006406B2 | EGFR-homing double-stranded RNA vector for systemic cancer treatment | Chemistry; Metallurgy | 5 | Active |
| US5677329A | Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit EGF receptor tyrosine kinase | Chemistry; Metallurgy | 4 | Expired |
| US6358954B1 | PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same | Human Necessities | 4 | Expired |
| US7217737B2 | Method and compositions for inhibiting cell proliferative disorders | Chemistry; Metallurgy | 3 | Expired |
| US7927792B2 | Targeted double stranded RNA mediated cell killing | Human Necessities | 1 | Expired |
| US8119827B2 | Compounds for treatment of cell proliferative diseases | Chemistry; Metallurgy | 1 | Active |
| US8461166B2 | Polyalkylene glycol derivatives of inhibitors of epidermal growth factor receptor tyrosine kinase | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.